CEO SUMMARY: Financial pressures and a falling stock price impelled Neuromedical Systems, Inc. to revamp its sales and marketing plan for the PAPNET® System. During 1998, expect a new sales approach that supports a product with enhanced capabilities. Neuromedical is developing overseas markets while pursuing primary screening approval in the United States. EXPECT TO SEE […]
Neuromedical’s PAPNET® Undergoing Enhancement
After a difficult year, Neuromedical seeks to reposition its automated cytology system
- By Robert Michel
- > From the Volume V No. 2 - February 9, 1998 Issue
